Moderna shares rise as investors await its COVID vaccine data

Read MoreA surge in COVID-19 infections across the US is giving pharmaceutical companies working on vaccines the data they need.A surge in COVID-19 infections across the US is giving pharmaceutical companies working on vaccines the data they need.